Melrose outlines USD 125 million settlement concerning Melrose stock
Published on 10/18/2026 at 13:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSettlement and operating milestones
- Melrose disclosed a Garden Grove settlement package worth USD 125 million on October 13, 2026.
- First-half 2026 revenue reached GBP 1.87 billion, up 8.90 percent year over year.
- Melrose will publish its next trading update on November 18, 2026.
- Melrose carries a market capitalization of EUR 6.9 billion.
Melrose (ISIN GB00BNGDN821) disclosed a USD 125 million settlement package linked to the Garden Grove facility on October 13, 2026. The agreement still requires court approval, while GKN Aerospace expects a phased return to full capacity during the fourth quarter, according to Investegate.
Settlement puts a price on risk
The package includes a claims program of up to USD 100 million for residents and businesses, USD 15 million in civil enforcement penalties and USD 10 million in claims from emergency services and other authorities. The company also said its insurance position remains under review, keeping execution and legal outcomes relevant for the aerospace group.
Hargreaves Lansdown reported on October 13, 2026, that the settlement followed a chemical incident at Garden Grove and that the facility's return to full capacity remained conditional on regulatory approval. The site generated GBP 136 million in sales during fiscal year 2025, according to the RNS announcement carried by Hargreaves Lansdown.
What does the settlement change?
The key financial comparison is between the USD 125 million package and the Garden Grove site's GBP 136 million fiscal year 2025 sales. The settlement therefore addresses a material site-specific exposure, while the planned restart points to the operational issue investors will monitor alongside the legal process.
Three dated steps to watch
Melrose's recent chronology runs from fiscal year 2025 revenue of GBP 3.59 billion reported on February 28, 2026, to first-half 2026 revenue of GBP 1.87 billion, up 8.90 percent from the prior-year period, on August 4, 2026. Those figures are summarized by Simply Wall St. The October 13, 2026 Garden Grove update was the latest step, according to Investegate.
The next dated milestones are Melrose's trading update for the four months ended October 31, 2026, scheduled for November 18, 2026, and its fiscal year 2026 results, listed for February 26, 2027. Both dates are reported by Simply Wall St.
Gettex quote and company scale
The gettex quote stood at EUR 5.50 on October 18, 2026 at 7:14 p.m. CEST. Melrose carried a market capitalization of EUR 6.88 billion, with a 52-week range of EUR 5.08 to EUR 7.90 on the same quoted page. The primary listing is on the London Stock Exchange under ticker MRO, where the October 16, 2026 close was GBp 485.00.
The further course of trading is shown by the continuously updated real-time quote of Melrose stock.
Melrose stock facts
- Company: Melrose Industries PLC
- ISIN: GB00BNGDN821
- Ticker: MRO
- Primary exchange: London Stock Exchange
- Last gettex price (as of October 18, 2026, 7:14 p.m. CEST): EUR 5.50
- Market capitalization: EUR 6.9 billion (as of October 18, 2026)
- 52-week range: EUR 5.08-7.90 (as of October 18, 2026)
- Sector / Industry: Industrials / Aerospace
- Index membership: FTSE 100
Market context: Market report FTSE 100.
